2021

• August Hoel; Tarig Osman; Fredrik Hoel et al. (2021). Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model. (ekstern lenke)
• Øystein Solberg Eikrem; Spiros Kotopoulis; Mihaela-Lucia Popa et al. (2021). Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys. (ekstern lenke)

2016

• Øystein Solberg Eikrem; Philipp Strauss; Christian Beisland et al. (2016). Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. (ekstern lenke)
• Lea Zoe Landolt; Philipp Strauss; Hans-Peter Marti et al. (2016). Next generation sequencing: A tool for this generation of nephrologists. (ekstern lenke)
• Øystein Solberg Eikrem; Andreas Scherer; Lea Zoe Landolt et al. (2016). Development and Confirmation of Gene Classifiers of Human Clear Cell Renal Cell Carcinoma Using Next-Generation Sequencing [Abstract].. (ekstern lenke)
• Lea Zoe Landolt; Hans-Peter Marti; Christian Beisland et al. (2016). RNA extraction for RNA sequencing of archival renal tissues. (ekstern lenke)
• Lea Zoe Landolt; Øystein Solberg Eikrem; Gro Gausdal et al. (2016). Detection and Validation of Epithelial-to-Mesenchymal Transition(EMT) with Increased Expression of Axl and MMP-14 in Renal Cell Carcinoma. (ekstern lenke)
• Øystein Solberg Eikrem; Christian Beisland; Karin Margrethe Hjelle et al. (2016). Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. (ekstern lenke)

2018

• Philipp Strauss; Hans-Peter Marti; Christian Beisland et al. (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasibility of miR-Seq for disease exploration and biomarker development from biopsies with clear cell renal cell Carcinoma. (ekstern lenke)
• Philipp Strauss; Even Evjen Koch; Hans-Peter Marti et al. (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasability of miRNA-sequencing for disease exploration and biomarker development from biopsies with clear cell renal cell carcinoma. (ekstern lenke)
• Øystein Solberg Eikrem; Philipp Strauss; Miroslav Sekulic et al. (2018). Fabry nephropathy: Transcriptome sequencing of microdissected renal compartments from archival kidney biopsies at baseline, and after 5 & 10 years of enzyme replacement therapy. (ekstern lenke)

2023

• Ole Petter Nordbø; Lea Zoe Landolt; Øystein Solberg Eikrem et al. (2023). Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy. (ekstern lenke)

2020

• Lea Zoe Landolt; Giulio Spagnioli; Alexandre Hertig et al. (2020). Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches. (ekstern lenke)

2019

• Philipp Strauss; Øystein Solberg Eikrem; Camilla Tøndel et al. (2019). Fabry Nephropathy: First mRNA-seq Findings from Kidney Biopsies Before and After Enzyme Replacement Therapy. (ekstern lenke)
• Even Koch; Kenneth Finne; Øystein Solberg Eikrem et al. (2019). Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms. (ekstern lenke)
• Lea Zoe Landolt; Jessica Furriol; Janka Babickova et al. (2019). AXL targeting reduces fibrosis development in experimental unilateral ureteral obstruction. (ekstern lenke)
• Lea Zoe Landolt; Hans-Peter Marti (2019). Epithelial-to-mesenchymal transition in clear cell renal cell cancer and renal fibrosis. (ekstern lenke)

2017

• Lea Zoe Landolt; Øystein Solberg Eikrem; Philipp Strauss et al. (2017). Clear cell renal cell carcinoma is linked to epithelial-to-mesenchymal transition and to fibrosis. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin